BRPI1008382A8 - Extrato de oregano para vivacidade - Google Patents

Extrato de oregano para vivacidade

Info

Publication number
BRPI1008382A8
BRPI1008382A8 BRPI1008382A BRPI1008382A BRPI1008382A8 BR PI1008382 A8 BRPI1008382 A8 BR PI1008382A8 BR PI1008382 A BRPI1008382 A BR PI1008382A BR PI1008382 A BRPI1008382 A BR PI1008382A BR PI1008382 A8 BRPI1008382 A8 BR PI1008382A8
Authority
BR
Brazil
Prior art keywords
vividness
oregano extract
alertness
oregano
extract
Prior art date
Application number
BRPI1008382A
Other languages
English (en)
Inventor
Goralczyk Regina
Wittwer Jonas
Mohajeri Hasan
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI1008382A2 publication Critical patent/BRPI1008382A2/pt
Publication of BRPI1008382A8 publication Critical patent/BRPI1008382A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

EXTRATO DE ORÉGANO PARA VIVACIDADE. O extrato de orégano pode atuar como um estimulante, ainda que não interfira nos padrões de sono ou induza o nervosismo da maneira como muitos estimulantes, como, por exemplo, a cafeína, podem estimular. Ele também possui os benefícios de promover a vigilância reforçada, melhorando a atenção e a capacidade de foco em uma tarefa, e melhorando a vivacidade em geral.
BRPI1008382A 2009-02-20 2010-02-19 Extrato de oregano para vivacidade BRPI1008382A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15402309P 2009-02-20 2009-02-20
US22221309P 2009-07-01 2009-07-01
PCT/EP2010/052115 WO2010094761A2 (en) 2009-02-20 2010-02-19 Oregano extract for alertness

Publications (2)

Publication Number Publication Date
BRPI1008382A2 BRPI1008382A2 (pt) 2015-08-25
BRPI1008382A8 true BRPI1008382A8 (pt) 2017-07-25

Family

ID=42341707

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008382A BRPI1008382A8 (pt) 2009-02-20 2010-02-19 Extrato de oregano para vivacidade

Country Status (7)

Country Link
US (1) US20120142786A1 (pt)
EP (1) EP2398340A2 (pt)
JP (2) JP2012518618A (pt)
KR (1) KR20110129905A (pt)
CN (1) CN102438464B (pt)
BR (1) BRPI1008382A8 (pt)
WO (1) WO2010094761A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2417967A1 (en) 2010-07-29 2012-02-15 Visiotact Pharma A transmucosal composition containing anthocyanins for alleviating a visual discomfort
JP5986793B2 (ja) * 2012-04-26 2016-09-06 小川香料株式会社 セイボリーエキスの製造方法
BR112014032948A2 (pt) * 2012-07-02 2017-06-27 Dsm Ip Assets Bv cápsulas contendo timoquinona
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物
KR20170054501A (ko) * 2014-09-15 2017-05-17 케민 인더스트리즈, 인코포레이티드 인지 기능을 개선시키기 위한 식물 추출물
HRP20220479T1 (hr) 2016-06-01 2022-05-27 Athira Pharma, Inc. Spojevi
WO2019055550A2 (en) * 2017-09-12 2019-03-21 Jina Pharmaceuticals, Inc. METHODS FOR PREPARING COMPOSITIONS CONTAINING THYMOQUINONE
JP7187479B2 (ja) * 2017-11-28 2022-12-12 シャープ株式会社 ストレス低減方法および集中度向上方法
CN108419702A (zh) * 2018-01-16 2018-08-21 淄博南庚商贸有限公司 一种兔掌套
CN108157217A (zh) * 2018-01-16 2018-06-15 淄博南庚商贸有限公司 一种猫掌套
EP3794421A4 (en) 2018-05-09 2022-12-21 Cavh Llc SYSTEMS AND PROCEDURES FOR DRIVING INTELLIGENCE ASSIGNMENT BETWEEN VEHICLES AND MOTORWAYS
AU2022314068A1 (en) 2021-07-23 2024-01-18 LeonaBio, Inc. Methods of treating parkinson's disease and/or lewy body disease or disorder(s)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002451B (el) * 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
RU2114629C1 (ru) * 1997-04-10 1998-07-10 Бабаскина Людмила Ивановна Сбор лекарственных трав, обладающий общеукрепляющим и нормализующим гормональный статус в климактерическом периоде действием
JP2004002237A (ja) * 2002-05-31 2004-01-08 Noriko Yagi 老化防止ハーブ
US7067159B2 (en) * 2003-12-05 2006-06-27 New Chapter, Inc. Methods for treating prostate cancer with herbal compositions
ATE460081T1 (de) * 2004-07-21 2010-03-15 Alltech Inc Zusammensetzung und ihre verwendung zur bekämpfung von protozoen-infektionen von tieren
ES2399667T3 (es) * 2006-08-09 2013-04-02 Dsm Ip Assets B.V. Nuevos agentes para el tratamiento de trastornos conectados con neurotransmisión deteriorada
US20100240768A1 (en) * 2007-10-18 2010-09-23 Ann Fowler Novel nutraceuticalcompositions containing thymol and/or p-cymene or plant extracts for cognition

Also Published As

Publication number Publication date
WO2010094761A3 (en) 2010-10-21
CN102438464B (zh) 2014-09-24
JP2015038131A (ja) 2015-02-26
US20120142786A1 (en) 2012-06-07
WO2010094761A2 (en) 2010-08-26
JP2012518618A (ja) 2012-08-16
KR20110129905A (ko) 2011-12-02
BRPI1008382A2 (pt) 2015-08-25
CN102438464A (zh) 2012-05-02
EP2398340A2 (en) 2011-12-28

Similar Documents

Publication Publication Date Title
CL2015001207A1 (es) Composición para prevenir o tratar diabetes, diabesidad o complicaciones diabéticas, que comprende un análogo de oxintomodulina; y uso de la composición.
WO2010094761A3 (en) Oregano extract for alertness
BR112016000954A2 (pt) processo para fracionamento da biomassa lignocelulósica; líquor, polpa ou hidrolisado enzimático de organossolve; e uso de um líquido de tratamento para fracionamento de biomasssa lignocelulósica
CL2014002406A1 (es) Metodo para el tratamiento de la depresion refractaria o resistente al taratamiento que comprende administrar esketamina por via intravenosa o intranasal sola o en combinacion con uno o mas antidepresivos; composicion farmaceutica; y su uso en el tratamiento de la depresion refractaria o resistente al tratamiento.
BR112014012398A2 (pt) gerenciamento de desempenho e energia de computação com estrutura de dados de desempenho de firmware
BRPI0917120A2 (pt) método, e, meio legível por computador.
BRPI0722259A2 (pt) Método para produção de um vestuário absorvente, e vestuário absorvente produzido de acordo com o método
BRPI0810375A2 (pt) Pré-tratamento termoquímico combinado e refino de biomassa lignocelulósica
CL2013001433A1 (es) Composicion que comprende al menos una n-acetil lactosamina, al menos un oligosacarido sialilado al menos un oligosacarido fucosilado; y su uso en la prevencion de infecciones respiratorias agudas y/o para aliviar los sintomas de dichas infecciones.
CU20140082A7 (es) Pirimidinas y triazinas fusionadas sustituidas y sus uso
CL2012003643A1 (es) Compuesto analogo del glucagon; composicion que comprende dicho compuesto; uso del compuesto para tratar y/o prevencion de obesidad, dislipidemia o hipertension.
ECSP13012379A (es) Pirimidinas y triazinas condensadas y su uso
MX2016002640A (es) Autentificacion de suministro a traves de una respuesta de reto por tiempo.
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BR112014026740A2 (pt) anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo
CR20110029A (es) Moduladores de diamino-piridina, pirimidina, y piridazina del receptor h4 de histamina
EA201590878A1 (ru) Использование ингибиторов теломеразы для лечения миелопролиферативных нарушений и миелопролиферативных неоплазм
BR112012001973A2 (pt) gerador de vapor, e, processo para operar o gerador de vapor
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
BR112015005422A2 (pt) folha de vidro e dispositivo que inclui a referida folha de vidro
BR112015030640A2 (pt) processo e sistema para produzir um metanol purificado
BRPI1000030A2 (pt) métodos para tratar esclerose múltipla em um paciente, para aumentar a capacidade de caminhar, para tratar os sintomas da esclerose múltipla, e, composição.
BR112015030685A2 (pt) método para diferenciar células-tronco, células, biobanco de células, uso das células e composição terapêutica
BRPI0921012A2 (pt) inserto e cortador que pode ser montado com o inserto.
CL2011003154A1 (es) Compuestos derivados de pirazinooxazepina, activador del receptor de serotonina 5-ht2c, composicion farmaceutica que los comprende; y su uso en el tratamiento y/o profilaxis de sintomas del aparato urinario inferior, obesidad y/o prolapso de organos.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A23L 27/10 (2016.01), A61K 31/00 (2006.01), A61K 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL